You have 9 free searches left this month | for more free features.

Torisel

Showing 1 - 25 of 129

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma Trial in New York (Cytoreductive surgery, Perifosine, Temsirolimus)

Active, not recruiting
  • Brain Tumor, Recurrent
  • +4 more
  • Cytoreductive surgery
  • +2 more
  • New York, New York
  • +1 more
Jun 9, 2022

Advanced Cancer Trial in Houston (Temsirolimus, Bevacizumab, Paclitaxel)

Active, not recruiting
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Advanced Cancers Trial in Houston (Temsirolimus, Metformin)

Active, not recruiting
  • Advanced Cancers
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

High Grade Glioma, Glioma, Glioma, Malignant Trial in Phoenix (Temsirolimus)

Not yet recruiting
  • High Grade Glioma
  • +3 more
  • Phoenix, Arizona
    St. Joseph's Hospital and Medical Center
Mar 6, 2023

Metastatic Renal Cell Carcinoma Trial in Lebanon, Burlington (Sunitinib, Temsirolimus)

Active, not recruiting
  • Metastatic Renal Cell Carcinoma
  • Lebanon, New Hampshire
  • +1 more
Aug 9, 2022

Diffuse Intrinsic Pontine Glioma Trial in Houston (Radiation Therapy, Temsirolimus, Vorinostat)

Active, not recruiting
  • Diffuse Intrinsic Pontine Glioma
  • Radiation Therapy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 5, 2022

Kidney Cancer Trial in Houston (Pazopanib, Temsirolimus, Quality of Life Assessment)

Completed
  • Kidney Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 24, 2021

Relapsed Bladder Cancer Trial in France (Temsirolimus)

Completed
  • Relapsed Bladder Cancer
  • Bordeaux, France
  • +8 more
Apr 9, 2021

Acute Myeloblastic Leukemia Trial in Germany (sodium chloride solution 0.9%, temsirolimus)

Completed
  • Acute Myeloblastic Leukemia
  • Berlin, Germany
  • +4 more
Nov 10, 2021

Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma Trial in New York (other, drug,

Completed
  • Adult Anaplastic Astrocytoma
  • +8 more
  • Laboratory Biomarker Analysis
  • +3 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jun 28, 2021

Carcinoma, Endometrioid, mTOR Protein Trial in Barcelona, Madrid, Valencia (Temsirolimus)

Completed
  • Carcinoma, Endometrioid
  • mTOR Protein
  • Barcelona, Spain
  • +2 more
Nov 25, 2020

Chronic Limb Ischemia Trial in United States (Temsirolimus, Saline)

Unknown status
  • Chronic Limb Ischemia
  • Little Rock, Arkansas
  • +7 more
Jun 9, 2020

Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

Active, not recruiting
  • Advanced Malignant Neoplasm
  • +38 more
  • Bevacizumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Hemangioendothelioma of Liver Trial in Shanghai (Sirolimus Oral Product, propranolol)

Not yet recruiting
  • Hemangioendothelioma of Liver
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center Shanghai Jiaotong University
May 23, 2020

Advanced Cancer, Solid Tumor Trial in Houston (Vemurafenib, Everolimus, Temsirolimus)

Completed
  • Advanced Cancer
  • Solid Tumor
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 1, 2020

Advanced Cancer Trial in Houston (Sirolimus, Vorinostat, Everolimus)

Unknown status
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 10, 2020

Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7 Trial in Chicago, Saint Louis

Completed
  • Recurrent Breast Carcinoma
  • +5 more
  • Chicago, Illinois
  • +1 more
Feb 13, 2020

Sarcoma Trial in Baltimore (temsirolimus plus liposomal doxorubicin)

Completed
  • Sarcoma
  • temsirolimus plus liposomal doxorubicin
  • Baltimore, Maryland
    Johns Hopkins University
Mar 8, 2019

Advanced Cancer Trial in Houston (Doxil, Bevacizumab, Temsirolimus)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Apr 9, 2019

Non-Hodgkin's Lymphoma Trial in Worldwide (temsirolimus)

Completed
  • Non-Hodgkin's Lymphoma
  • Miami, Florida
  • +30 more
May 17, 2019

Hepatocellular Carcinoma Trial in San Francisco, Chicago (sorafenib with temsirolimus)

Completed
  • Hepatocellular Carcinoma
  • sorafenib with temsirolimus
  • San Francisco, California
  • +1 more
May 7, 2019

Prostate Cancer Trial in Cleveland, Willoughby Hills (drug, biological, genetic, other)

Completed
  • Prostate Cancer
  • Cleveland, Ohio
  • +2 more
Aug 19, 2019

Temsirolimus Drug Use Investigation

Completed
  • Renal Cell Carcinoma
  • Fukuoka-shi, Fukuoka PREF, Japan
    Kyusyu University Hospital
Sep 14, 2018